{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:19:32Z","timestamp":1793827172957,"version":"4.6.1"},"reference-count":0,"publisher":"Portico","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2017.53.5.2613690","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:11:23Z","timestamp":1497917483000},"page":"283","source":"Crossref","is-referenced-by-count":45,"title":["Brodalumab: The first anti-IL-17 receptor agent for psoriasis"],"prefix":"10.3730","volume":"53","author":[{"family":"Puig, L.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1320","published-online":{"date-parts":[[2017]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T09:26:03Z","timestamp":1685438763000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dd881b"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2017.53.5.2613690","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}